0001209191-15-083296.txt : 20151203 0001209191-15-083296.hdr.sgml : 20151203 20151203171723 ACCESSION NUMBER: 0001209191-15-083296 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151201 FILED AS OF DATE: 20151203 DATE AS OF CHANGE: 20151203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cara Therapeutics, Inc. CENTRAL INDEX KEY: 0001346830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE PARROTT DRIVE CITY: SHELTON STATE: CT ZIP: 06484 BUSINESS PHONE: 203-567-1500 MAIL ADDRESS: STREET 1: ONE PARROTT DRIVE CITY: SHELTON STATE: CT ZIP: 06484 FORMER COMPANY: FORMER CONFORMED NAME: Cara Therapeutics Inc DATE OF NAME CHANGE: 20051213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Menzaghi Frederique Ph.D. CENTRAL INDEX KEY: 0001597152 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36279 FILM NUMBER: 151268107 MAIL ADDRESS: STREET 1: C/O CARA THERAPEUTICS, INC. STREET 2: 1 PARROTT DRIVE CITY: SHELTON STATE: CT ZIP: 06484 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-12-01 0 0001346830 Cara Therapeutics, Inc. CARA 0001597152 Menzaghi Frederique Ph.D. C/O CARA THERAPEUTICS, INC. 1 PARROTT DRIVE SHELTON CT 06484 0 1 0 0 VP-Research & Development Common Stock 2015-12-01 4 S 0 6000 16.21 D 141000 D This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2015. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.01 - $16.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. /s/Darren DeStefano, Attorney-in-Fact 2015-12-03